# Omeprazole

## OKWE 20mg

| TAH Drug Code      | [OOKW](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OOKW)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ulcer of duodenum. Gastroesophageal reflux disease. Gastric ulcer. Erosive esophagitis. Zollinger-Ellison Syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Peptic or duodenal ulcer: adult， initial 20 mg QD for 2 weeks; if necessary， 20- 40mg QD for another 2 weeks Gastric ulcer & GERD: 20 mg QD for 4 weeks; if necessary， 20- 40mg QD for another 4 weeks Zollinger-Ellison syndrome: Initial， 60 mg QD; may increase up to 120 mg once daily; doses greater than 80 mg/day should be administered in divided doses， and the dose should be individualized for each patient.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Individuals who are allergic to omeprazole， benzimidazole derivatives， or any excipient of this product. As with other proton pump inhibitors， omeprazole should not be used in combination with nelfinavir.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Common Dermatologic: Rash (2% ) Gastrointestinal: Abdominal pain (5% )， Constipation (2% )， Diarrhea (4% )， Flatulence (3% )， Nausea (4% )， Regurgitation， Acid (2% )， Vomiting (3% ) Neurologic: Asthenia (2% )， Dizziness (2% )， Headache (7% ) Respiratory: Upper respiratory infection (Adult， 2% ) Other: Fever (1 to less than 2 years， 33% ) Serious Dermatologic: Cutaneous lupus erythematosus， Erythema multiforme， Stevens-Johnson syndrome， Toxic epidermal necrolysis Endocrine metabolic: Hypomagnesemia Gastrointestinal: Atrophic gastritis， Clostridium difficile diarrhea， Fundic gland polyposis of stomach， Pancreatitis Hematologic: Hemolytic anemia Hepatic: Hepatic encephalopathy， Hepatic necrosis， Liver failure Immunologic: Anaphylaxis Musculoskeletal: Fracture of bone， Hip fracture， Rhabdomyolysis Renal: Tubulointerstitial nephritis， acute Other: Angioedema |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| More Info          | [UpToDate](https://www.uptodate.com/contents/omeprazole-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

